🚚 Free Worldwide Shipping on All Orders!Shop Now
Selgian Tablets
HomeStore

Selgian Tablets

Selgian Tablets

Selegiline hydrochloride is an inhibitor of monoamine oxidase (IMAO type B) at the therapeutic dose in the dog; thus it modifies the concentration of monoaminergic neurotransmitters. 

It is indicated for use as follows:1. Treatment of behavioural disorders of purely emotional origin such as depression and anxiety.2. In association with behaviour therapy, treatment of signs of emotional origin observed in behavioural conditions such as overactivity, separation problems, generalised phobia and unsocial behaviour. Emotional disorders are characterised by a modification of feeding, drinking, auto-stimulatory behaviour, sleep, exploratory behaviour, aggression related to fear and
or irritation, social behaviour and somatic disorders (tachycardia, emotional micturition).

Select Size
From $10.20

Original: $33.99

-70%
Selgian Tablets—

$33.99

$10.20

More Images

Selgian Tablets - Image 2
Selgian Tablets - Image 3

Selgian Tablets

Selegiline hydrochloride is an inhibitor of monoamine oxidase (IMAO type B) at the therapeutic dose in the dog; thus it modifies the concentration of monoaminergic neurotransmitters. 

It is indicated for use as follows:1. Treatment of behavioural disorders of purely emotional origin such as depression and anxiety.2. In association with behaviour therapy, treatment of signs of emotional origin observed in behavioural conditions such as overactivity, separation problems, generalised phobia and unsocial behaviour. Emotional disorders are characterised by a modification of feeding, drinking, auto-stimulatory behaviour, sleep, exploratory behaviour, aggression related to fear and
or irritation, social behaviour and somatic disorders (tachycardia, emotional micturition).

Product Information

Shipping & Returns

Description

Selegiline hydrochloride is an inhibitor of monoamine oxidase (IMAO type B) at the therapeutic dose in the dog; thus it modifies the concentration of monoaminergic neurotransmitters. 

It is indicated for use as follows:1. Treatment of behavioural disorders of purely emotional origin such as depression and anxiety.2. In association with behaviour therapy, treatment of signs of emotional origin observed in behavioural conditions such as overactivity, separation problems, generalised phobia and unsocial behaviour. Emotional disorders are characterised by a modification of feeding, drinking, auto-stimulatory behaviour, sleep, exploratory behaviour, aggression related to fear and
or irritation, social behaviour and somatic disorders (tachycardia, emotional micturition).